Physician profile
Levin Fairchild
NPI 1306423322
$1,462.11
in general payments reported to CMS, 2019-2025
8 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $552 · 2024: $775 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $490.84 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $327.18 | 2023-2025 | Hawkone, Sonicision, Endoflip |
| Innovation Technologies INC | $149.66 | 2023 | Irrisept |
| Cook Medical LLC | $142.69 | 2024 | Zenith |
| Pacira Pharmaceuticals Incorporated | $138.65 | 2023-2024 | Iovera, Exparel |
| Ethicon US, LLC | $130.95 | 2024 | Echelon Endopath, Stratafix |
| Merit Medical Systems INC | $67.55 | 2025 | Endomaxx Stent and Delivery System, Esophyx |
| Lsi Solutions INC | $14.59 | 2024 | Cor-Knot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Levin Fairchild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.